Skip to content
FDA Approves Second Monoclonal Antibody Medication for Alzheimer’s
1/9/23, 12:00 AM
FDA Approves Novel Rapid-Acting Oral Antidepressant
8/22/22, 12:00 AM
FDA Issues Warning About Dental Risk With Transmucosal Buprenorphine
1/14/22, 12:00 AM
Caplyta Approved for Bipolar Depression in Adults
12/20/21, 12:00 AM
Today Is Deadline to Recertify in Modified Clozapine REMS, Re-enroll Patients
11/15/21, 12:00 AM
FDA Narrows Use of New Alzheimer’s Drug to Early Stage Patients
7/9/21, 12:00 AM
Lybalvi Approved for Schizophrenia, Bipolar I Disorder in Adults
6/11/21, 12:00 AM
Alzheimer’s Antibody Therapy Receives Accelerated Approval Amid Controversy
6/8/21, 12:00 AM
FDA Authorizes Marketing of New Aid to Diagnose Autism
6/3/21, 12:00 AM
First
Prev
2
3
4
5
6
Next
Last
This is a search field with an auto-suggest feature attached.
There are no suggestions because the search field is empty.
Follow us on X
Follow us on Instagram
Follow us on LinkedIn
Follow us on YouTube
Sign up to receive each post directly into your inbox:
News From Current Issue
Youth Chatbot Use Is on the Rise—Not That They’re Telling Anyone
One Dose of Psilocybin May Alter Brain Structure
APA Pushes Back on Aetna, Sends Numerous Comments to CMS, and More
Read This Week's Update
